Insight Molecular Diagnostics Inc.
IMDX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $1 | $2 | $1 |
| % Growth | -49.8% | -75.8% | 43.9% | – |
| Cost of Goods Sold | $0 | $0 | $1 | $1 |
| Gross Profit | $0 | $0 | $1 | $1 |
| % Margin | 53.5% | 67.6% | 62% | 40% |
| R&D Expenses | $4 | $3 | $3 | $2 |
| G&A Expenses | $3 | $3 | $3 | $3 |
| SG&A Expenses | $4 | $4 | $4 | $3 |
| Sales & Mktg Exp. | $1 | $1 | $1 | $0 |
| Other Operating Expenses | $3 | $3 | $1 | $29 |
| Operating Expenses | $11 | $10 | $8 | $34 |
| Operating Income | -$11 | -$10 | -$7 | -$34 |
| % Margin | -4,249.2% | -1,900% | -318% | -2,262.9% |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | -$11 | -$10 | -$7 | -$34 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$11 | -$10 | -$7 | -$34 |
| % Margin | -4,174.6% | -1,880.7% | -312% | -2,255.1% |
| EPS | -0.34 | -0.304 | -0.26 | -1.928 |
| % Growth | -11.8% | -17.2% | 86.5% | – |
| EPS Diluted | -0.34 | -0.304 | -0.26 | -1.928 |
| Weighted Avg Shares Out | 32 | 32 | 26 | 17 |
| Weighted Avg Shares Out Dil | 32 | 32 | 26 | 17 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $0 | $1 |
| EBITDA | -$10 | -$9 | -$6 | -$33 |
| % Margin | -3,938.8% | -1,768% | -287.7% | -2,215.2% |